Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Actin gamma 1 pseudogene 3 (ACTG1P3) is a human pseudogene related to the actin, gamma 1 gene. Pseudogenes like ACTG1P3 are typically non-functional genetic elements—they resemble known genes but contain mutations or sequence changes preventing their expression as a functional protein. ACTG1P3 is sometimes listed in genomic datasets as a locus similar to ACTG1, one of the major actin isoforms involved in cell cytoskeleton and motility, but ACTG1P3 itself is not involved in protein synthesis, biological regulation, disease, or drug interaction, and is not a therapeutic target[2]. ACTG1P3 should not be considered a molecular target for drug discovery, clinical biomarker development, or biological study except as part of genomic or evolutionary research regarding pseudogenes. If you intended *ACTG1* (the protein-coding gene), refer instead to "Actin gamma 1 (ACTG1)," which has known biological and disease roles[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Actin gamma 1 pseudogene 3 (ACTG1P3).